Materials and Methods
All the clinical isolates of S. pneumoniae reported here were recovered from October 1988 to September 1998 in the microbiology laboratory of Chiba Children's Hospital, a 200-bed scaled tertiary-care hospital located in the east-central part of Chiba City.
Isolates were identified as S. pneumoniae by their susceptibility to optochin and their bile solubility.
Minimum inhibitory concentrations (MICs) were determined by broth microdilution assay in cation- Isolates of S. pneumoniae were serotyped or serogrouped in Nagasaki University Hospital or Juntendo University Hospital by using the capsular swelling method with antisera obtained from Stantens seruminstitut (Copenhagen, Denmark).
Pulsed-field gel electrophoresis (PFGE) was performed for the isolates from a recurrent case with pneumonia as described previously4) with the following modifications: isolates were grown for 6 h in 6 ml of Tripticase soy broth. Preparation of agarose-embedded genomic DNA was done by using a GenPathTM group I reagent kit (Bio-Rad, Tokyo) . Chromosomal DNA were digested with Smal and ApaI (Takara, Tokyo) . The patterns obtained with each enzyme were compared. DNA fragments were separated on 1% agarose gels using the GenPathTM system (Bio-Rad, Tokyo), with running conditions of 6 V/cm at 14 and a switching time of 1 to 14 sec for 18.5 hours. PFGE patterns were digitized and the positions were 
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Antimicrobial susceptibilities
MICs of five antimicrobial agents tested for the control strain were within the acceptable quality control ranges provided by NCCLS3).
The table summarizes the susceptibility to five antimicrobial agents examined. The overall rate of resistance to penicillin G was 57%, of which 48% had intermediate resistance and 9% had high-level resistance. There were no significant differences in penicillin resistance level among isolated sites. The proportions of isolates resistant to cefotaxime, imipenem, erythromycin and clindamycin was 33%, 9%,70%, and 65%, respectively. All isolates resistant to cefotaxime (5 isolates) also demonstrated resistance to penicillin. Seventeen isolates (74% of all the cases) were resistant to 2 or more classes of antimicrobial agents.
Serotyping
Serotyping was performed on 17 isolates. The identified serotypes were 19 (6 isolates), 6 (5 isolates), 23 (3 isolates) , 14 (2 isolates) , and 5 (1 isolate). Fig. 2 shows the relationship between serotypes and peni-cillin susceptibilities. All eleven isolates resistant to penicillin were limited to serotypes 6, 19, or 23.
PFGE analysis of isolates from a case with a recurrent episode
One patient had 2 episodes of bacteremic pneumonia. The time interval between the first and second episodes was about 7 months. Both isolates were the same serotype (6) and showed the same pattern of antimicrobial susceptibility. PFGE analysis with SmaI or ApaI restriction digestion of those isolates subsequently characterized them as identical isolates. Discussion S. pneumoniae that are not only resistant to penicillins and cephems but also multidrug-resistant have increased worldwide in recent years. At our hospital, we have also seen an increase in the frequency of infections due to pneumococci resistant to penicillin, cefotaxime, erythromycin, and clindamycin. We found the overall rates of resistance to penicillin and to cefotaxime to be 57% and 33%, respectively. It is noteworthy that similar rates of resistance to penicillin have been reported in recent nationwide hospitalbased surveys of bacterial meningitis in Japan5). Therefore, the increasing frequency of penicillin, cefotaxime, and multidrug-resistant S. pneumoniae has required changes in the empirical approach to antibiotic selection when treating such infections. In particular, the common antibiotic treatment for bacterial meningitis of ampicillin plus cefotaxime has recently seen a greater failure rate. With this in mind, while waiting for the results of susceptibility testing, we now recommend panipenem/betamipron therapy for meningitis patients admitted to our hospital when Gram-positive cocci are seen on CSF smears and rapid pneumococcal antigen detection is positive6).
Most pneumococcal infections among children are caused by a limited number of serotypes1)7)
Among our patients, most isolates of S. pneumoniae belong to serotypes 6, 14, 19, or 23, which are also the most common "childhood types". And, as others have observed, all 11 of our isolates of S. pneumoniae that were resistant to penicillin were serotypes 6, 19, or 23. As management of pneumococcal infections has become more difficult, the prevention of infection by vaccination has become more important. In our study, 61% of the systemic pneumococcal infections were found in children younger than 24 months old.
Unfortunately, a poor response to the polysaccharide antigen is well recognized in this population7). The success of the conjugate vaccines to Haemophilus influenzae type b has encouraged work on similar vaccines for S. pneumoniae. For that purpose, it is necessary to select candidate vaccine types and then monitor their susceptibility over time with community-based surveillance of pneumococcal serotypes. In this study, we encountered a patient who had a recurrent episode of bacteremic pneumonia about 7 months after the first episode. Both serotypes and PFGE patterns revealed that the isolates from both episodes were concordant. However, it is possible that the initial therapy may have been adequate to treat pneumonia but inadequate to eradicate the colonization of the nasopharynx and/or sinuses, or perhaps the patient was reinfected with the identical genotyped strain. The findings of this case suggest that cultures of the nasopharynx or sputum are needed as a follow-up for such patients. PFGE is a useful tool not only for epidemiological tracking but also to elucidate the etiology of recurrence.
(This study was presented in June 1999 at the 99th General Meeting of the American Society for Microbiology, Chicago, Illinois.)
